01276 HENGRUI PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 9.72X | Oper Margin | 25.7% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 22.6% |
| Total Debt/Equity | 0.2% | Return on Equity | 13.9% |
| Price/Book | N/A | Return on Assets | 12.6% |
| (HKD 86.200) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 6,733.50 | 4,738.38 | 4,377.87 |
|---|---|---|---|
| Net Profit Growth (%) | +42.1 | +8.2 | N/A |
| Earnings Per Share (HKD) | 1.056 | 0.745 | 0.689 |
| Earnings Per Share Growth (%) | +41.7 | +8.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | 81.62 | 115.66 | 125.04 |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-06 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | |
| Cover Period (mths) | 6 | 6 | NA | |
|---|---|---|---|---|
| Turnover | 15,761 | 13,601 | +15.9 | |
| Operating Result | 5,092 | 3,786 | +34.5 | |
| Associates | -41.467 | -34.377 | +20.6 | |
| Profit Before Taxation | 5,051 | 3,752 | +34.6 | |
| Taxation | 596.264 | 323.468 | +84.3 | |
| Profit /( Loss) After Taxation | 4,455 | 3,428 | +30.0 | |
| Minority Interests | 4.564 | -3.616 | -226.2 | |
| Net Profit | 4,450 | 3,432 | +29.7 | |
| Earnings Per Share () | 0.7629 | 0.5806 | +31.4 | |
| Announcement Date | 2025-08-20 | 2025-08-20 | NA |
* Annualised
Last Update Time: 2025-09-06 21:40:25
